| McMichael, Amy |
CCCA, NCT04207931: Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (): a Multicenter Prospective Study |
|
|
| Recruiting | 4 | 250 | US | Topical steroid class I-II, Clobetasol, Betamethasone Dipropionate, or Fluocinonide, Triamcinolone Acetonide, Kenaolog, Doxycyline, Doxy-100, Targadox, Oracea, Minoxidil, Rogaine | Wake Forest University Health Sciences, The Skin of Color Society | Central Centrifugal Cicatricial Alopecia (CCCA) | 10/25 | 01/26 | | |
CCCA, NCT05416320: Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia |
|
|
| Withdrawn | 1 | 10 | US | Calcipotriol, Dovonex, Subject's already prescribed drug | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 11/23 | 12/23 | | |
| Recruiting | 1 | 15 | US | azelaic acid, Finacea, usual medication for CCCA | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/25 | 06/25 | | |
NCT03569956: Shaving Satisfaction in Males With Skin Irritation From Shaving |
|
|
| Active, not recruiting | N/A | 40 | US | 556 Razor | Wake Forest University Health Sciences, Procter and Gamble | Pseudofolliculitis Barbae | 04/19 | 02/25 | | |
NCT05759338: A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia |
|
|
| Completed | N/A | 100 | US | Revian Red All LED cap | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/24 | 06/24 | | |
NCT04764331: A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia |
|
|
| Recruiting | N/A | 5 | US | Revian Red All LED cap, Revian Red | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 03/25 | 08/25 | | |
| Palmer, Victoria Jane |
| Recruiting | 1 | 15 | US | azelaic acid, Finacea, usual medication for CCCA | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/25 | 06/25 | | |
ACTRN12614000457640: Getting to the CORE: testing a co-design technique to optimise psychosocial recovery outcomes for people affected by mental illness in the community mental health setting. |
|
|
| Active, not recruiting | N/A | 270 | | | The University of Melbourne, Mental Illness Research Fund, Psychiatric Illness and Intellectual Disability Donations Trust Fund | Bipolar Disorder, Anxiety Disorders, Major Depressive Disorders, Psychotic Disorders, Schizophrenia, Personality Disorders, Panic Disorders | | | | |
| Larrondo, Jorge F |
| Recruiting | 1 | 15 | US | azelaic acid, Finacea, usual medication for CCCA | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/25 | 06/25 | | |
| Obeime, Ivie M |
| Completed | 3 | 209 | Europe, Canada, US | TMB-001, Matching Vehicle | Timber Pharmaceuticals Inc., LEO Pharma | Ichthyosis | 06/24 | 09/24 | | |
| Recruiting | 1 | 15 | US | azelaic acid, Finacea, usual medication for CCCA | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/25 | 06/25 | | |
NCT05759338: A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia |
|
|
| Completed | N/A | 100 | US | Revian Red All LED cap | Wake Forest University Health Sciences | Central Centrifugal Cicatricial Alopecia | 06/24 | 06/24 | | |
